middle.news
Anteris Secures Medicare Reimbursement to Boost US PARADIGM Trial Activation
7:04pm on Tuesday 28th of April, 2026 AEST
•
Healthcare
Read Story
Anteris Secures Medicare Reimbursement to Boost US PARADIGM Trial Activation
7:04pm on Tuesday 28th of April, 2026 AEST
Key Points
CMS national coverage policy enables Medicare reimbursement
Supports U.S. site activation for PARADIGM Trial
Randomized study comparing DurAVR to existing TAVRs
Enrollment target of approximately 1000 patients
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Anteris Technologies Global (ASX:AVR)
OPEN ARTICLE